...
首页> 外文期刊>Ultrasonics, Ferroelectrics and Frequency Control, IEEE Transactions on >Enhanced gene expression of systemically administered plasmid DNA in the liver with therapeutic ultrasound and microbubbles
【24h】

Enhanced gene expression of systemically administered plasmid DNA in the liver with therapeutic ultrasound and microbubbles

机译:通过治疗性超声和微泡增强肝脏中全身给药质粒DNA的基因表达

获取原文
获取原文并翻译 | 示例
           

摘要

Ultrasound-mediated delivery (USMD) of novel therapeutic agents in the presence of microbubbles is a potentially safe and effective method for gene therapy offering many desired characteristics, such as low toxicity, potential for repeated treatment, and organ specificity. In this study, we tested the capability of USMD to improve gene expression in mice livers using glycogen storage disease Type Ia as a model disease under systemic administration of naked plasmid DNA. Image-guided therapeutic ultrasound was used in two studies to provide therapeutic ultrasound to mice livers. In the first study, involving wild-type mice, control animals received naked plasmid DNA (pG6Pase 150 ?????? g) via the tail vein, followed by an infusion of microbubbles; the treated animals additionally received therapeutic ultrasound (1 MHz). Following the procedure, the animals were left to recover and were subsequently euthanized after 2 d and liver samples were extracted. Reverse transcription polymerase chain reaction (RT-PCR) assays were performed on the samples to quantify mRNA expression. In addition, Western blot assays of FLAG-tagged glucose-6-phosphatase (G6Pase) were performed to evaluate protein expression. Ultrasound-exposed animals showed a 4-fold increase in G6Pase RNA in the liver, in comparison with control animals. Furthermore, results from Western blot analysis demonstrated a 2-fold increased protein expression in ultrasound-exposed animals after two days ( p < 0.05). A second pilot study was performed with G6Pase knockout mice, and the animals were monitored for correction of hypoglycemia over a period of 3 weeks before tissue analysis. The RT-PCR assays of samples from these animals demonstrated increased G6Pase RNA in the liver following ultrasound treatment. These results demonstrate that USMD can increase gene expression of systemically injected naked pDNA in the liver and also provide insight into the development of realistic approaches that can be translated into - linical practice.
机译:在存在微泡的情况下,新型治疗药物的超声介导递送(USMD)是一种潜在的安全有效的基因治疗方法,可提供许多所需的特性,例如低毒性,重复治疗的潜力和器官特异性。在这项研究中,我们测试了USMD在裸质粒DNA全身给药下使用糖原贮积病Ia型作为模型病在小鼠肝脏中改善基因表达的能力。在两项研究中使用了图像引导的治疗超声,以向小鼠肝脏提供治疗超声。在涉及野生型小鼠的第一项研究中,对照动物通过尾静脉接受裸质粒DNA(pG6Pase 150×g),然后注入微泡。被治疗的动物还接受了治疗性超声波(1 MHz)。按照该程序,让动物恢复,并在2天后安乐死并提取肝脏样品。在样品上进行了逆转录聚合酶链反应(RT-PCR)分析以定量mRNA表达。此外,进行了FLAG标记的葡萄糖-6磷酸酶(G6Pase)的蛋白质印迹分析,以评估蛋白质表达。与对照动物相比,暴露于超声的动物肝脏中的G6Pase RNA增加了4倍。此外,蛋白质印迹分析的结果表明,两天后超声暴露的动物的蛋白质表达增加了2倍(p <0.05)。用G6Pase基因敲除小鼠进行了第二项先导研究,并在组织分析之前的3周内监测了动物的低血糖纠正。这些动物样品的RT-PCR分析表明,超声处理后肝脏中G6Pase RNA的增加。这些结果表明,USMD可以增加肝脏中全身注射的裸露pDNA的基因表达,并且还可以洞察可以转化为临床实践的现实方法的发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号